| Schizophrenia | Bipolar affective disorder | Major depressive disorder | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Suicide | Non-suicide | p-value | Suicide | Non-suicide | p-value | Suicide | Non-suicide | p-value |
 | N = 82 | N = 164 |  | N = 23 | N = 46 |  | N = 67 | N = 134 |  |
Age at laboratory tests (years), mean ± SD | 31.1 ± 9.1 | 31.5 ± 8.6 | 0.699a | 36.5 ± 11.6 | 35.9 ± 10.0 | 0.830a | 52.6 ± 15.2 | 54.1 ± 15.2 | 0.519a |
Age at first admission (years) | 29.1 ± 9.3 | 29.3 ± 8.9 | 0.859a | 34.0 ± 11.6 | 32.7 ± 10.4 | 0.620a | 51.6 ± 15.1 | 53.2 ± 14.8 | 0.494a |
Number of admissions, mean ± SD | 2.2 ± 2.3 | 2.4 ± 2.5 | 0.638a | 2.5 ± 1.8 | 2.5 ± 2.1 | >0.99a | 1.6 ± 1.3 | 1.6 ± 1.0 | 0.895a |
Body mass index (kg/m2), mean ± SD | 22.1 ± 3.7 | 23.1 ± 4.1 | 0.086a | 23.8 ± 3.6 | 23.9 ± 3.0 | 0.93a | 22.8 ± 3.2 | 22.9 ± 3.5 | 0.894a |
Sex, male, n (%) | 42(51) | 80(49) | 0.787b | 14(61) | 29(63) | >0.99b | 30(45) | 56(42) | 0.763b |
Socio-economic status, n (%) | Â | Â | 0.479b | Â | Â | 0.457b | Â | Â | 0.259b |
High | 19(27) | 33(21) | Â | 3(14) | 12(27) | Â | 13(24) | 39(31) | Â |
Middle | 32(45) | 84(53) | Â | 12(55) | 22(50) | Â | 28(51) | 66(53) | Â |
Low | 20(28) | 41(26) | Â | 7(32) | 10(23) | Â | 14(25) | 20(16) | Â |
Use of atypical antipsychotics, n (%) | 16 (19.5) | 43 (26.2) | 0.245b | 4 (17.4) | 11 (23.9) | 0.536b | 4 (6.0) | 7 (5.2) | 0.826b |
Comorbid medical disease | Â | Â | Â | Â | Â | Â | Â | Â | Â |
None | 75(91.5) | 155(94.5) | 0.361b | 17(73.9) | 40(87.0) | 0.178b | 47(70.1) | 81(60.4) | 0.178b |
Endocrine disease | 2(2.4) | 1 (0.6) | Â | 0 | 0 | Â | 4(6.0) | 13(9.7) | Â |
Cardiovascular disease | 0 | 1(0.6) | Â | 2(8.7) | 2(3.3) | Â | 12(17.9) | 22(16.4) | Â |
Liver disease | 0 | 3(1.8) | Â | 1(4.3) | 0 | Â | 0 | 3(2.2) | Â |
Neurological disease | 3(3.7) | 1(0.6) | Â | 2(8.7) | 1(2.2) | Â | 3(4.5) | 3(2.2) | Â |
Cancer | 0 | 0 | Â | 0 | 0 | Â | 0 | 3(2.2) | Â |
Othersc | 2(2.4) | 3(1.8) | Â | 1(4.3) | 3(6.5) | Â | 1(1.5) | 9(6.7) | Â |